Effectiveness of medical therapy for treatment of idiopathic frequent premature ventricular complexes.
Jacky K K TangJason A GencherNathaniel M HawkinsZachary W LaksmanAndrew D KrahnMatthew T BennettBrett HeilbronSantabhanu ChakrabartiJohn A Yeung-Lai-WahMarc William DeyellPublished in: Journal of cardiovascular electrophysiology (2021)
In patients with idiopathic frequent PVCs, BB, and CCB have limited effectiveness in PVC reduction. Class I and III AADs have superior effectiveness for medical therapy in symptomatic patients, but only achieved complete PVC resolution suppression in one-third of patients.